Pathophysiology of lower extremity edema in acute heart failure revisited

American Journal of Medicine

Volumn 125, Issue 11, 2012, Pages

  Breidthardt, Tobias ^a,b   Irfan, Affan ^a,c   Klima, Theresia ^a   Drexler, Beatrice ^a   Balmelli, Cathrin ^a   Arenja, Nisha ^a   Socrates, Thenral ^a   Ringger, Rebekka ^a   Heinisch, Corinna ^a   Ziller, Ronny ^a   Schifferli, Jürg ^a   Meune, Christophe ^a,d   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ROYAL DERBY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

B type natriuretic peptide; Central venous pressure; Copeptin; Edema; Heart failure; Left ventricular ejection fraction

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE; COPEPTIN; SODIUM;

ACUTE HEART FAILURE; AGED; ALBUMIN BLOOD LEVEL; ANASARCA; ANKLE EDEMA; ARTICLE; CENTRAL VENOUS PRESSURE; DYSPNEA; EMERGENCY WARD; FEMALE; GLOMERULUS FILTRATION RATE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART STRESS; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CENTRAL VENOUS PRESSURE; EDEMA; FEMALE; GLYCOPEPTIDES; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPONATREMIA; LOWER EXTREMITY; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84867843894     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.12.015     Document Type: Article

References (43)

1. M. Gheorghiade, F. Zannad, G. Sopko Acute heart failure syndromes: current state and framework for future research Circulation 112 25 2005 3958 3968
2. L.J. Kozak, M.F. Owings, M.J. Hall National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data Vital Health Stat 13 158 2005 1 199
3. T. Thom, N. Haase, W. Rosamond Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 113 6 2006 e85 e151
4. G.C. Fonarow, E. Corday Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry Heart Fail Rev 9 3 2004 179 185
5. J.G. Cleland, K. Swedberg, A. Cohen-Solal The Euro Heart Failure Survey of the EUROHEART survey programme A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York Eur J Heart Fail 2 2 2000 123 132
6. G.C. Fonarow, W.T. Abraham, N.M. Albert Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 153 1 2007 82.e1 82.e11
7. F. Zannad, A. Mebazaa, Y. Juilliere Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study Eur J Heart Fail 8 7 2006 697 705
8. L. De Luca, G.C. Fonarow, K.F. Adams Jr Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy Heart Fail Rev 12 2 2007 97 104
9. G.C. Fonarow The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure Rev Cardiovasc Med 4 Suppl 7 2003 S21 S30
10. E.H. Starling Physiologic forces involved in the causation of dropsy Lancet i 1896 1267 1270
11. L. Tavazzi, A.P. Maggioni, D. Lucci Nationwide survey on acute heart failure in cardiology ward services in Italy Eur Heart J 27 10 2006 1207 1215
12. R.W. Schrier Water and sodium retention in edematous disorders: role of vasopressin and aldosterone Am J Med 119 7 Suppl 1 2006 S47 S53
13. S. Cho, J.E. Atwood Peripheral edema Am J Med 113 7 2002 580 586
14. C. Thalhammer, M. Siegemund, M. Aschwanden Non-invasive central venous pressure measurement by compression ultrasound - a step into real life Resuscitation 80 10 2009 1130 1136
15. C. Thalhammer, M. Aschwanden, A. Odermatt Noninvasive central venous pressure measurement by controlled compression sonography at the forearm J Am Coll Cardiol 50 16 2007 1584 1589
16. H. Uthoff, C. Thalhammer, M. Potocki Central venous pressure at emergency room presentation predicts cardiac rehospitalization in patients with decompensated heart failure Eur J Heart Fail 12 5 2010 469 476
17. H. Uthoff, T. Breidthardt, T. Klima Central venous pressure and impaired renal function in patients with acute heart failure Eur J Heart Fail 13 4 2011 432 439
18. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 19 2008 2388 2442
19. T. Kawasaki, M. Ueno, K. Uezono Average urinary excretion of sodium in 24 hours can be estimated from a spot-urine specimen Jpn Circ J 46 9 1982 948 953
20. T. Hashimoto, F. Yagami, M. Owada, T. Sugawara, M. Kawamura Salt preference according to a questionnaire vs. dietary salt intake estimated by a spot urine method in participants at a health check-up center Intern Med 47 5 2008 399 403
21. M. Kawamura, Y. Kusano, T. Takahashi, M. Owada, T. Sugawara Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs Hypertens Res 29 6 2006 397 402
22. N.G. Morgenthaler, J. Struck, C. Alonso, A. Bergmann Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 1 2006 112 119
23. T. Reichlin, W. Hochholzer, C. Stelzig Incremental value of copeptin for rapid rule out of acute myocardial infarction J Am Coll Cardiol 54 1 2009 60 68
24. T. Mueller, A. Gegenhuber, W. Poelz, M. Haltmayer Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay Clin Chem 50 6 2004 1104 1106
25. G.C. Fonarow, W.G. Stough, W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 8 2007 768 777
26. P. Meyer, O.J. Ekundayo, C. Adamopoulos A propensity-matched study of elevated jugular venous pressure and outcomes in chronic heart failure Am J Cardiol 103 6 2009 839 844
27. K. Damman, V.M. van Deursen, G. Navis, A.A. Voors, D.J. van Veldhuisen, H.L. Hillege Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease J Am Coll Cardiol 53 7 2009 582 588
28. W. Mullens, Z. Abrahams, G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 7 2009 589 596
29. R. Agarwal, M.J. Andersen, J.H. Pratt On the importance of pedal edema in hemodialysis patients Clin J Am Soc Nephrol 3 1 2008 153 158
30. C. Mueller, T. Breidthardt, K. Laule-Kilian, M. Christ, A.P. Perruchoud The integration of BNP and NT-proBNP into clinical medicine Swiss Med Wkly 137 1-2 2007 4 12
31. A. Maisel, C. Mueller, K. Adams Jr State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 9 2008 824 839
32. M. Gheorghiade, W.T. Abraham, N.M. Albert Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 8 2007 980 988
33. L. Klein, C.M. O'Connor, J.D. Leimberger Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study Circulation 111 19 2005 2454 2460
34. S.R. Goldsmith Treatment options for hyponatremia in heart failure Heart Fail Rev 14 2 2009 65 73
35. R.M. Oren Hyponatremia in congestive heart failure Am J Cardiol 95 9A 2005 2B 7B
36. L. Bettari, M. Fiuzat, G.M. Felker, C.M. O'Connor Significance of hyponatremia in heart failure Heart Fail Rev 17 1 2012 17 26
37. M.L. Zeidel Hyponatremia: mechanisms and newer treatments Endocr Pract 16 5 2010 882 887
38. M.H. Rosner, C. Ronco Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism Congest Heart Fail 16 Suppl 1 2010 S7 S14
39. N.G. Morgenthaler Copeptin: a biomarker of cardiovascular and renal function Congest Heart Fail 16 Suppl 1 2010 S37 S44
40. E. Pasini, R. Aquilani, M. Gheorghiade, F.S. Dioguardi Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach Ital Heart J 4 4 2003 232 235
41. T.B. Horwich, K. Kalantar-Zadeh, R.W. MacLellan, G.C. Fonarow Albumin levels predict survival in patients with systolic heart failure Am Heart J 155 5 2008 883 889
42. M. Gheorghiade, M.A. Konstam, J.C. Burnett Jr Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials JAMA 297 12 2007 1332 1343
43. M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 12 2007 1319 1331